SEC Form 4 · accession 0000899243-18-019661
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chirag K. Patel
Director · 10% Owner
Period of report
Jul 5, 2018
Accepted (ET)
Jul 9, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Jul 5, 2018 | J | 21,269,420 | $0.00 | A | 21,269,420 | I | By Family Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common UnitsF2 | — | Jul 5, 2018 | J | 21,269,420 | A | — | — | Common Units | 21,269,420 | 21,269,420 | I |
Explanation of responses
- F1Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration.
- F2The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.